RADIANCE-HTN

STUDY IDENTIFIER:

RADIANCE-HTN

CONDITION:

Hypertension

CONTACT INFO:

Rose Peterson, RN   |   Rose.Peterson@allina.com   |   612-863-6051

DESCRIPTION:

Hypertension, or high blood pressure, affects over 1 billion people. Left untreated, high blood pressure can increase your risk of serious health problems such as heart attack, stroke, and kidney failure. Yet nearly 1 in 3 individuals with hypertension struggle to control their blood pressure despite being on medication.

If you and your physician have been unable to control your blood pressure, or are interested in an alternative to daily medications, you may be a candidate for the RADIANCE-HTN Clinical Study. The study is evaluating an investigative minimally-invasive, catheter-based procedure (the Paradise® Renal Denervation System) which may lower your blood pressure and reduce your need for blood pressure medications.

CRITERIA LIST/ QUALIFICATIONS:

  • Adults with documented history of essential hypertension
  • Average seated office BP ≥140/90 Hg at screening visit while on a stable regimen of at least 3 antihypertensive medications of different classes including a diuretic for at least 4 weeks prior to consent.
  • Complete this questionnaire to see if you qualify to participate in the Radiance-HTN Study.

INVESTIGATORS:

Yale Wang, MD

SPONSORS:

ReCor Medical

STATUS:

Open/Enrolling